

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.86228123 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.19789210 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.19789210 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.82948613 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82948613 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75945545 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.50856620 |
| 8 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.47016901 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34003112 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.28345754 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.28345754 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.28345754 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.28345754 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.28345754 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.28345754 |
| 16 | urea metabolic process (GO:0019627) | 5.25747349 |
| 17 | urea cycle (GO:0000050) | 5.25747349 |
| 18 | tryptophan catabolic process (GO:0006569) | 5.14441973 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 5.14441973 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 5.14441973 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.11130314 |
| 22 | kynurenine metabolic process (GO:0070189) | 5.10132164 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94869968 |
| 24 | neutrophil activation (GO:0042119) | 4.91879456 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.91177653 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.90306682 |
| 27 | complement activation, alternative pathway (GO:0006957) | 4.83031647 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.82569115 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.81263824 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.78976906 |
| 31 | negative regulation of cell killing (GO:0031342) | 4.78976906 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.77939819 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.75645875 |
| 34 | phospholipid efflux (GO:0033700) | 4.75194532 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 4.71667053 |
| 36 | protein carboxylation (GO:0018214) | 4.65798128 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.65798128 |
| 38 | microglial cell activation (GO:0001774) | 4.65751228 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.63830619 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.60946982 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 4.57914763 |
| 42 | regulation of fibrinolysis (GO:0051917) | 4.55833751 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.48584588 |
| 44 | glyoxylate metabolic process (GO:0046487) | 4.45430898 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 4.40596918 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 4.38161227 |
| 47 | regulation of complement activation (GO:0030449) | 4.36882340 |
| 48 | granulocyte activation (GO:0036230) | 4.36473543 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.32210646 |
| 50 | detection of other organism (GO:0098543) | 4.28177227 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.21736428 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 4.21736428 |
| 53 | macromolecular complex remodeling (GO:0034367) | 4.21736428 |
| 54 | bile acid metabolic process (GO:0008206) | 4.20434085 |
| 55 | phospholipid homeostasis (GO:0055091) | 4.17642539 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 4.13684905 |
| 57 | cellular extravasation (GO:0045123) | 4.12036144 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11578229 |
| 59 | cholesterol efflux (GO:0033344) | 4.08375464 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.08112248 |
| 61 | homocysteine metabolic process (GO:0050667) | 4.04859293 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 4.04416419 |
| 63 | cysteine metabolic process (GO:0006534) | 4.04142077 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 4.02102690 |
| 65 | negative regulation of sterol transport (GO:0032372) | 4.02102690 |
| 66 | response to peptidoglycan (GO:0032494) | 4.00095729 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.98622228 |
| 68 | detection of bacterium (GO:0016045) | 3.97140594 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.96333807 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.96211427 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.94472440 |
| 72 | response to host immune response (GO:0052572) | 3.91536705 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.91536705 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.91324403 |
| 75 | acylglycerol homeostasis (GO:0055090) | 3.90671443 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.90671443 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 3.84244885 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.83695623 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.81918055 |
| 80 | serine family amino acid catabolic process (GO:0009071) | 3.81229997 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 3.80979506 |
| 82 | bile acid and bile salt transport (GO:0015721) | 3.78424336 |
| 83 | regulation of platelet aggregation (GO:0090330) | 3.76670451 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75428842 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74936264 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 3.71318945 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.71318945 |
| 88 | fibrinolysis (GO:0042730) | 3.67570118 |
| 89 | lysine metabolic process (GO:0006553) | 3.66591781 |
| 90 | lysine catabolic process (GO:0006554) | 3.66591781 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.65488358 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65340507 |
| 93 | thrombin receptor signaling pathway (GO:0070493) | 3.65025015 |
| 94 | amine catabolic process (GO:0009310) | 3.63254673 |
| 95 | cellular biogenic amine catabolic process (GO:0042402) | 3.63254673 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.63206406 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.62539007 |
| 98 | leukocyte degranulation (GO:0043299) | 3.60589108 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59012784 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59012784 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.58777251 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58422630 |
| 103 | imidazole-containing compound metabolic process (GO:0052803) | 3.58212144 |
| 104 | ethanol oxidation (GO:0006069) | 3.58131512 |
| 105 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.57890036 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.57855635 |
| 107 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.57855635 |
| 108 | indolalkylamine metabolic process (GO:0006586) | 3.57697450 |
| 109 | cellular glucuronidation (GO:0052695) | 3.56625586 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56004857 |
| 111 | B cell mediated immunity (GO:0019724) | 3.54707122 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.54103313 |
| 113 | response to host (GO:0075136) | 3.50206458 |
| 114 | response to host defenses (GO:0052200) | 3.50206458 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.50206458 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.49833841 |
| 117 | macrophage activation (GO:0042116) | 3.49429128 |
| 118 | benzene-containing compound metabolic process (GO:0042537) | 3.45050370 |
| 119 | leukocyte aggregation (GO:0070486) | 3.44354371 |
| 120 | detection of biotic stimulus (GO:0009595) | 3.44194068 |
| 121 | regulation of platelet activation (GO:0010543) | 3.42862244 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 3.42143211 |
| 123 | complement activation (GO:0006956) | 3.41999045 |
| 124 | lipoprotein metabolic process (GO:0042157) | 3.40879284 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.40595438 |
| 126 | complement activation, classical pathway (GO:0006958) | 3.39463146 |
| 127 | cholesterol homeostasis (GO:0042632) | 3.38977238 |
| 128 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37338405 |
| 129 | plasma lipoprotein particle organization (GO:0071827) | 3.35740817 |
| 130 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35671888 |
| 131 | protein-lipid complex assembly (GO:0065005) | 3.35308139 |
| 132 | coenzyme catabolic process (GO:0009109) | 3.35056247 |
| 133 | sterol homeostasis (GO:0055092) | 3.34102385 |
| 134 | cellular amino acid catabolic process (GO:0009063) | 3.33518062 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33432808 |
| 136 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.33260822 |
| 137 | arginine metabolic process (GO:0006525) | 3.33111593 |
| 138 | protein activation cascade (GO:0072376) | 3.32468657 |
| 139 | respiratory burst (GO:0045730) | 3.29909693 |
| 140 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.29592388 |
| 141 | glutamate metabolic process (GO:0006536) | 3.28817034 |
| 142 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24045296 |
| 143 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.24030891 |
| 144 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.24030891 |
| 145 | cellular ketone body metabolic process (GO:0046950) | 3.23678205 |
| 146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.22183686 |
| 147 | regulation of cholesterol metabolic process (GO:0090181) | 3.21381111 |
| 148 | protein-lipid complex subunit organization (GO:0071825) | 3.21313796 |
| 149 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19501579 |
| 150 | activated T cell proliferation (GO:0050798) | 3.19426794 |
| 151 | uronic acid metabolic process (GO:0006063) | 3.18994338 |
| 152 | glucuronate metabolic process (GO:0019585) | 3.18994338 |
| 153 | linoleic acid metabolic process (GO:0043651) | 3.17980783 |
| 154 | fatty acid oxidation (GO:0019395) | 3.17693593 |
| 155 | dendritic cell migration (GO:0036336) | 3.16638986 |
| 156 | dendritic cell chemotaxis (GO:0002407) | 3.16015818 |
| 157 | regulation of cholesterol homeostasis (GO:2000188) | 3.14818112 |
| 158 | lipid oxidation (GO:0034440) | 3.13888501 |
| 159 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12435814 |
| 160 | fatty acid beta-oxidation (GO:0006635) | 3.10967039 |
| 161 | drug catabolic process (GO:0042737) | 3.08842721 |
| 162 | blood coagulation, intrinsic pathway (GO:0007597) | 3.08523062 |
| 163 | acetyl-CoA metabolic process (GO:0006084) | 3.06472562 |
| 164 | carboxylic acid catabolic process (GO:0046395) | 3.06067768 |
| 165 | organic acid catabolic process (GO:0016054) | 3.06067768 |
| 166 | superoxide anion generation (GO:0042554) | 3.03543895 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03460074 |
| 168 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02474548 |
| 169 | mast cell activation (GO:0045576) | 3.00700803 |
| 170 | regulation of leukocyte degranulation (GO:0043300) | 2.99615798 |
| 171 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99150061 |
| 172 | regulation of memory T cell differentiation (GO:0043380) | 2.97725125 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.95541455 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95091909 |
| 175 | neutrophil mediated immunity (GO:0002446) | 2.94561741 |
| 176 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.91249186 |
| 177 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.91174638 |
| 178 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90900976 |
| 179 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89125776 |
| 180 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88383929 |
| 181 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78250466 |
| 182 | positive regulation of type 2 immune response (GO:0002830) | 2.77239610 |
| 183 | myeloid leukocyte activation (GO:0002274) | 2.76603453 |
| 184 | adenosine receptor signaling pathway (GO:0001973) | 2.76371934 |
| 185 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75973439 |
| 186 | positive regulation of B cell mediated immunity (GO:0002714) | 2.75757227 |
| 187 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.75757227 |
| 188 | tolerance induction (GO:0002507) | 2.75625978 |
| 189 | response to interleukin-15 (GO:0070672) | 2.75624001 |
| 190 | B cell receptor signaling pathway (GO:0050853) | 2.74993048 |
| 191 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74296047 |
| 192 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74031460 |
| 193 | regulation of tolerance induction (GO:0002643) | 2.71975660 |
| 194 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.71055944 |
| 195 | negative regulation of interleukin-17 production (GO:0032700) | 2.70481909 |
| 196 | myeloid leukocyte mediated immunity (GO:0002444) | 2.70323918 |
| 197 | negative regulation of adaptive immune response (GO:0002820) | 2.69794795 |
| 198 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67965854 |
| 199 | protein neddylation (GO:0045116) | 2.67423797 |
| 200 | regulation of interleukin-17 production (GO:0032660) | 2.66387230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.04136036 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.68581248 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.84514998 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41329079 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.19360292 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.18327929 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17860863 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.54475592 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.48344852 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66361518 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.62791754 |
| 12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.51162394 |
| 13 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49217024 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34890158 |
| 15 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.00029217 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99084132 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98327480 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.94195149 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92787376 |
| 20 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.90700472 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86459957 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82885560 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80344108 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77443429 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74352380 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74343813 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73650524 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73409617 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73039312 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72590551 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.68440246 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65974725 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63948475 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63591289 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62941852 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60177735 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60166336 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58971255 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58439444 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58206447 |
| 41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57708618 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57465162 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56403878 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55090855 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54763924 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51878524 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51525447 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49135522 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46716662 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46011454 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43806643 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42433424 |
| 53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42376986 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40111916 |
| 55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35050824 |
| 56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26299257 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24632566 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20306081 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20083406 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19551208 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18538510 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.18410818 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17390044 |
| 64 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.17008823 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.14191189 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13442766 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11289706 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10382815 |
| 69 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10147635 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08929770 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08816384 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08322041 |
| 73 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.07902763 |
| 74 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07122121 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05561582 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01882868 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01711769 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01096715 |
| 79 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.98403791 |
| 80 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.97822222 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97120244 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96997985 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95398992 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94439108 |
| 85 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.94032301 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93332952 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93112689 |
| 88 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92262192 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92167752 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90403889 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88244111 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87719911 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87549459 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86663110 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86356706 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86172134 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86073023 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85925828 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85925828 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85479337 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84953024 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84084046 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82758286 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82647997 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82624356 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82318035 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82085580 |
| 108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81504243 |
| 109 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80552189 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80430266 |
| 111 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79691543 |
| 112 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78695521 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78493418 |
| 114 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78368956 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77057915 |
| 116 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76814067 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75933168 |
| 118 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.75749972 |
| 119 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.75557537 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.75313529 |
| 121 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75242882 |
| 122 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.72671656 |
| 123 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.72646620 |
| 124 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72509870 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72364302 |
| 126 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72314731 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71655893 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71242702 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.70539045 |
| 130 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69899401 |
| 131 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.68838200 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.68812877 |
| 133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68523481 |
| 134 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.68207585 |
| 135 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68197859 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68139316 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68062105 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67615467 |
| 139 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.67594068 |
| 140 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.66352400 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66348370 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66277378 |
| 143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.64221644 |
| 144 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.63926582 |
| 145 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.63802448 |
| 146 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.62628838 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62597314 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61235999 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.59884517 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59545392 |
| 151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59256737 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58999112 |
| 153 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.58905550 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58061561 |
| 155 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.57718136 |
| 156 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.57386099 |
| 157 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57132562 |
| 158 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56638631 |
| 159 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56638460 |
| 160 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56635544 |
| 161 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.56045262 |
| 162 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.55787795 |
| 163 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55199343 |
| 164 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55108989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.99501807 |
| 2 | MP0005360_urolithiasis | 5.71438176 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.25301982 |
| 4 | MP0005365_abnormal_bile_salt | 5.07514977 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32530941 |
| 6 | MP0009840_abnormal_foam_cell | 3.89484984 |
| 7 | MP0003252_abnormal_bile_duct | 3.70339377 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.20173393 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.02480777 |
| 10 | MP0008004_abnormal_stomach_pH | 2.94629087 |
| 11 | * MP0005671_abnormal_response_to | 2.91636819 |
| 12 | MP0000685_abnormal_immune_system | 2.70496687 |
| 13 | MP0001800_abnormal_humoral_immune | 2.63772842 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.62840530 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.62097442 |
| 16 | MP0001790_abnormal_immune_system | 2.50251082 |
| 17 | MP0005387_immune_system_phenotype | 2.50251082 |
| 18 | * MP0002723_abnormal_immune_serum | 2.42660069 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.30566097 |
| 20 | MP0005083_abnormal_biliary_tract | 2.25744967 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.20179232 |
| 22 | * MP0001819_abnormal_immune_cell | 2.18173417 |
| 23 | MP0005332_abnormal_amino_acid | 2.13112524 |
| 24 | MP0003828_pulmonary_edema | 2.12932425 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.12345369 |
| 26 | * MP0000609_abnormal_liver_physiology | 2.07362354 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.01216106 |
| 28 | MP0003436_decreased_susceptibility_to | 2.01146442 |
| 29 | * MP0002118_abnormal_lipid_homeostasis | 1.94292180 |
| 30 | MP0002132_abnormal_respiratory_system | 1.83192488 |
| 31 | MP0009697_abnormal_copulation | 1.82174956 |
| 32 | MP0002398_abnormal_bone_marrow | 1.74607954 |
| 33 | * MP0010155_abnormal_intestine_physiology | 1.72083700 |
| 34 | MP0005451_abnormal_body_composition | 1.68152830 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.67362516 |
| 36 | MP0009764_decreased_sensitivity_to | 1.65310133 |
| 37 | MP0003195_calcinosis | 1.64296299 |
| 38 | MP0005670_abnormal_white_adipose | 1.63663902 |
| 39 | * MP0000716_abnormal_immune_system | 1.63493508 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.62483740 |
| 41 | MP0003866_abnormal_defecation | 1.60527562 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.60014755 |
| 43 | MP0004510_myositis | 1.60014304 |
| 44 | MP0003011_delayed_dark_adaptation | 1.57843877 |
| 45 | MP0002254_reproductive_system_inflammat | 1.57546261 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.57331486 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.51014251 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.44635340 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.43945325 |
| 50 | * MP0002405_respiratory_system_inflammati | 1.41691664 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.40625099 |
| 52 | MP0003868_abnormal_feces_composition | 1.38012648 |
| 53 | MP0001851_eye_inflammation | 1.35928851 |
| 54 | MP0003303_peritoneal_inflammation | 1.35025852 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.33410508 |
| 56 | * MP0002429_abnormal_blood_cell | 1.32024893 |
| 57 | MP0000604_amyloidosis | 1.31953032 |
| 58 | MP0000858_altered_metastatic_potential | 1.31442103 |
| 59 | MP0008260_abnormal_autophagy | 1.30458130 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.29851333 |
| 61 | MP0002722_abnormal_immune_system | 1.29845317 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28596078 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.26366074 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.26366074 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.26315219 |
| 66 | MP0000343_altered_response_to | 1.23747043 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.19604155 |
| 68 | MP0009278_abnormal_bone_marrow | 1.19415756 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.18688546 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.18620543 |
| 71 | MP0004381_abnormal_hair_follicle | 1.17545321 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.16977857 |
| 73 | MP0001764_abnormal_homeostasis | 1.15996616 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.14892539 |
| 75 | MP0003724_increased_susceptibility_to | 1.13938625 |
| 76 | MP0003690_abnormal_glial_cell | 1.13819219 |
| 77 | MP0008469_abnormal_protein_level | 1.13173095 |
| 78 | MP0009763_increased_sensitivity_to | 1.11240444 |
| 79 | MP0005310_abnormal_salivary_gland | 1.10892857 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.09504544 |
| 81 | * MP0002419_abnormal_innate_immunity | 1.08776345 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.06260885 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.05683699 |
| 84 | MP0000598_abnormal_liver_morphology | 1.05295139 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.03214282 |
| 86 | MP0003075_altered_response_to | 1.00050267 |
| 87 | MP0003186_abnormal_redox_activity | 0.99362019 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.98706775 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.98619279 |
| 90 | MP0001853_heart_inflammation | 0.98050299 |
| 91 | MP0003045_fibrosis | 0.94498475 |
| 92 | MP0002971_abnormal_brown_adipose | 0.94437767 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.93773031 |
| 94 | MP0005647_abnormal_sex_gland | 0.91538383 |
| 95 | * MP0001663_abnormal_digestive_system | 0.91316717 |
| 96 | MP0004484_altered_response_of | 0.88623338 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.88342259 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.87647632 |
| 99 | MP0002928_abnormal_bile_duct | 0.86343996 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.84499434 |
| 101 | * MP0005334_abnormal_fat_pad | 0.82470679 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.81021319 |
| 103 | MP0005164_abnormal_response_to | 0.80697388 |
| 104 | MP0000249_abnormal_blood_vessel | 0.80668896 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.80496796 |
| 106 | MP0004130_abnormal_muscle_cell | 0.79738560 |
| 107 | MP0005408_hypopigmentation | 0.78911397 |
| 108 | * MP0009642_abnormal_blood_homeostasis | 0.78443602 |
| 109 | MP0005390_skeleton_phenotype | 0.76837706 |
| 110 | * MP0001845_abnormal_inflammatory_respons | 0.76443587 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.76395766 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.76235696 |
| 113 | MP0005023_abnormal_wound_healing | 0.74965035 |
| 114 | MP0004883_abnormal_blood_vessel | 0.74236729 |
| 115 | * MP0000230_abnormal_systemic_arterial | 0.74165747 |
| 116 | MP0006082_CNS_inflammation | 0.73228218 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.72686811 |
| 118 | * MP0005025_abnormal_response_to | 0.72391667 |
| 119 | MP0009053_abnormal_anal_canal | 0.70584858 |
| 120 | MP0001881_abnormal_mammary_gland | 0.69824785 |
| 121 | MP0003448_altered_tumor_morphology | 0.69543004 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.68796748 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.68655024 |
| 124 | MP0003279_aneurysm | 0.68336289 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.68238892 |
| 126 | * MP0005666_abnormal_adipose_tissue | 0.67713056 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.66195596 |
| 128 | MP0005166_decreased_susceptibility_to | 0.66034576 |
| 129 | MP0003787_abnormal_imprinting | 0.65926252 |
| 130 | MP0009785_altered_susceptibility_to | 0.65047239 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.64478377 |
| 132 | MP0005535_abnormal_body_temperature | 0.64116843 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.64081978 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.63921518 |
| 135 | MP0005410_abnormal_fertilization | 0.60902644 |
| 136 | MP0002796_impaired_skin_barrier | 0.60543030 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.60169666 |
| 138 | MP0002060_abnormal_skin_morphology | 0.59473080 |
| 139 | MP0003795_abnormal_bone_structure | 0.59313619 |
| 140 | MP0003879_abnormal_hair_cell | 0.58363562 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.57951770 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.57037413 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.55947449 |
| 144 | MP0001968_abnormal_touch/_nociception | 0.55665586 |
| 145 | MP0005275_abnormal_skin_tensile | 0.55358585 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.54826997 |
| 147 | MP0009115_abnormal_fat_cell | 0.54549880 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.54315674 |
| 149 | MP0001756_abnormal_urination | 0.53356606 |
| 150 | MP0004947_skin_inflammation | 0.53345072 |
| 151 | MP0008874_decreased_physiological_sensi | 0.52646180 |
| 152 | MP0002295_abnormal_pulmonary_circulatio | 0.52281044 |
| 153 | * MP0005000_abnormal_immune_tolerance | 0.51523885 |
| 154 | MP0005220_abnormal_exocrine_pancreas | 0.50948383 |
| 155 | * MP0002693_abnormal_pancreas_physiology | 0.48708577 |
| 156 | MP0002133_abnormal_respiratory_system | 0.47994763 |
| 157 | MP0005388_respiratory_system_phenotype | 0.47994763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.21534690 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.57725315 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.12826913 |
| 4 | Complement deficiency (HP:0004431) | 5.94950873 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92007659 |
| 6 | Petechiae (HP:0000967) | 5.84912512 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.78321566 |
| 8 | Xanthomatosis (HP:0000991) | 5.75001158 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.40482268 |
| 10 | Purpura (HP:0000979) | 5.25896977 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.22273507 |
| 12 | Abnormality of macrophages (HP:0004311) | 5.03786287 |
| 13 | Joint hemorrhage (HP:0005261) | 4.97516356 |
| 14 | Stomatitis (HP:0010280) | 4.80239484 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.62581365 |
| 16 | Myositis (HP:0100614) | 4.60963283 |
| 17 | Abnormality of complement system (HP:0005339) | 4.50623229 |
| 18 | Optic neuritis (HP:0100653) | 4.42787408 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 4.42787408 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 4.41373845 |
| 21 | Orchitis (HP:0100796) | 4.39044249 |
| 22 | Hypolipoproteinemia (HP:0010981) | 4.30005883 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13827986 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.10846716 |
| 25 | Epidermoid cyst (HP:0200040) | 4.02579236 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01974243 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.90004569 |
| 28 | Myocardial infarction (HP:0001658) | 3.80409076 |
| 29 | Hyperammonemia (HP:0001987) | 3.70378038 |
| 30 | Glomerulonephritis (HP:0000099) | 3.68202633 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66141666 |
| 32 | Encephalitis (HP:0002383) | 3.60726076 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53951504 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.46614701 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.41573993 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.40159059 |
| 37 | Fat malabsorption (HP:0002630) | 3.39678583 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38177956 |
| 39 | Obstructive lung disease (HP:0006536) | 3.38177956 |
| 40 | Ketosis (HP:0001946) | 3.36156280 |
| 41 | Episodic fever (HP:0001954) | 3.34426721 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.32915633 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.30831233 |
| 44 | Recurrent fungal infections (HP:0002841) | 3.28658783 |
| 45 | Hyperglycinemia (HP:0002154) | 3.27270710 |
| 46 | Recurrent skin infections (HP:0001581) | 3.25831239 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.25727265 |
| 48 | Hyperglycinuria (HP:0003108) | 3.23611236 |
| 49 | Hypoglycemic coma (HP:0001325) | 3.18841549 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 3.18245286 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 3.18168794 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.13500174 |
| 53 | Abnormal platelet function (HP:0011869) | 3.11829515 |
| 54 | Impaired platelet aggregation (HP:0003540) | 3.11829515 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08098747 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 3.07397994 |
| 57 | Chronic otitis media (HP:0000389) | 3.05225292 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.04685394 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 3.04685394 |
| 60 | Keratoconjunctivitis (HP:0001096) | 3.04070625 |
| 61 | Mitral stenosis (HP:0001718) | 3.02623148 |
| 62 | Meningitis (HP:0001287) | 3.02591093 |
| 63 | Vascular calcification (HP:0004934) | 2.98715155 |
| 64 | Arterial thrombosis (HP:0004420) | 2.94539546 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.92498821 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90767182 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90767182 |
| 68 | Vasculitis (HP:0002633) | 2.84742594 |
| 69 | Esophageal varix (HP:0002040) | 2.81889263 |
| 70 | Urticaria (HP:0001025) | 2.80761608 |
| 71 | Increased IgM level (HP:0003496) | 2.78391979 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.77233891 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75900720 |
| 74 | Leukocytosis (HP:0001974) | 2.74003340 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.73732889 |
| 76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73208649 |
| 77 | Chest pain (HP:0100749) | 2.72551281 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.69826655 |
| 79 | Skin nodule (HP:0200036) | 2.66676519 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.64727189 |
| 81 | Nephritis (HP:0000123) | 2.64202429 |
| 82 | T lymphocytopenia (HP:0005403) | 2.60968861 |
| 83 | Steatorrhea (HP:0002570) | 2.60288559 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.56540065 |
| 85 | Amyloidosis (HP:0011034) | 2.56338391 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.56191972 |
| 87 | Delayed CNS myelination (HP:0002188) | 2.51457264 |
| 88 | Gingival bleeding (HP:0000225) | 2.50183157 |
| 89 | Hemoptysis (HP:0002105) | 2.49317594 |
| 90 | Joint swelling (HP:0001386) | 2.48876981 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.47506126 |
| 92 | Bruising susceptibility (HP:0000978) | 2.47375606 |
| 93 | Gingivitis (HP:0000230) | 2.47036518 |
| 94 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.46567003 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 2.46567003 |
| 96 | Axonal loss (HP:0003447) | 2.35957594 |
| 97 | Menorrhagia (HP:0000132) | 2.35837969 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.34522297 |
| 99 | Anorexia (HP:0002039) | 2.33484471 |
| 100 | Vertigo (HP:0002321) | 2.31869828 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.31730272 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.30780248 |
| 103 | Ketoacidosis (HP:0001993) | 2.29270877 |
| 104 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.26342165 |
| 105 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.26342165 |
| 106 | Ventricular fibrillation (HP:0001663) | 2.23862896 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.23048097 |
| 108 | Dyschromatopsia (HP:0007641) | 2.21576421 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 2.20910991 |
| 110 | Cholecystitis (HP:0001082) | 2.20910991 |
| 111 | Gangrene (HP:0100758) | 2.20737029 |
| 112 | Hemorrhage of the eye (HP:0011885) | 2.16741804 |
| 113 | Increased IgE level (HP:0003212) | 2.16672642 |
| 114 | Abnormal ciliary motility (HP:0012262) | 2.13565567 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.13014782 |
| 116 | Metabolic acidosis (HP:0001942) | 2.12316646 |
| 117 | Acanthocytosis (HP:0001927) | 2.12187478 |
| 118 | Panhypogammaglobulinemia (HP:0003139) | 2.11592909 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.11359917 |
| 120 | Hepatosplenomegaly (HP:0001433) | 2.11346678 |
| 121 | Abnormality of T cells (HP:0002843) | 2.11202321 |
| 122 | Cholelithiasis (HP:0001081) | 2.10895434 |
| 123 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10389308 |
| 124 | Hypochromic anemia (HP:0001931) | 2.07489093 |
| 125 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.06360528 |
| 126 | Peritonitis (HP:0002586) | 2.06280877 |
| 127 | Eosinophilia (HP:0001880) | 2.03057386 |
| 128 | Hypertriglyceridemia (HP:0002155) | 2.02980275 |
| 129 | Autoimmune hemolytic anemia (HP:0001890) | 2.02909921 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 2.01417041 |
| 131 | Osteomyelitis (HP:0002754) | 2.00860481 |
| 132 | Spontaneous abortion (HP:0005268) | 2.00690980 |
| 133 | Pancreatitis (HP:0001733) | 1.99226243 |
| 134 | Spastic diplegia (HP:0001264) | 1.99134368 |
| 135 | Chronic sinusitis (HP:0011109) | 1.98887361 |
| 136 | Decreased central vision (HP:0007663) | 1.98404587 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.96987944 |
| 138 | Granulocytopenia (HP:0001913) | 1.96749439 |
| 139 | Pulmonary embolism (HP:0002204) | 1.96211430 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.95578685 |
| 141 | Upper motor neuron abnormality (HP:0002127) | 1.95560068 |
| 142 | Thrombophlebitis (HP:0004418) | 1.94690886 |
| 143 | Irritability (HP:0000737) | 1.94075365 |
| 144 | Hypoglycemic seizures (HP:0002173) | 1.94066711 |
| 145 | Retinal atrophy (HP:0001105) | 1.91674898 |
| 146 | Keratitis (HP:0000491) | 1.91438443 |
| 147 | Abnormality of proline metabolism (HP:0010907) | 1.90894114 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.90894114 |
| 149 | Increased serum ferritin (HP:0003281) | 1.90662092 |
| 150 | Recurrent viral infections (HP:0004429) | 1.90556597 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90368584 |
| 152 | Pustule (HP:0200039) | 1.90291894 |
| 153 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89987099 |
| 154 | Gastrointestinal inflammation (HP:0004386) | 1.88627130 |
| 155 | Polyneuropathy (HP:0001271) | 1.87828508 |
| 156 | Muscle fibrillation (HP:0010546) | 1.86982035 |
| 157 | Abnormality of the prostate (HP:0008775) | 1.86794702 |
| 158 | Recurrent sinusitis (HP:0011108) | 1.86442507 |
| 159 | Dicarboxylic aciduria (HP:0003215) | 1.86327465 |
| 160 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86327465 |
| 161 | Abnormality of the pleura (HP:0002103) | 1.81083025 |
| 162 | Malnutrition (HP:0004395) | 1.80568484 |
| 163 | Poikilocytosis (HP:0004447) | 1.79654902 |
| 164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78856047 |
| 165 | Amaurosis fugax (HP:0100576) | 1.78380836 |
| 166 | Abnormality of the endocardium (HP:0004306) | 1.77915872 |
| 167 | Recurrent abscess formation (HP:0002722) | 1.76845228 |
| 168 | Late onset (HP:0003584) | 1.76657074 |
| 169 | Stroke (HP:0001297) | 1.76239528 |
| 170 | Rickets (HP:0002748) | 1.76084649 |
| 171 | Lethargy (HP:0001254) | 1.75052701 |
| 172 | Neonatal onset (HP:0003623) | 1.74650023 |
| 173 | Epistaxis (HP:0000421) | 1.73446401 |
| 174 | Abnormal biliary tract physiology (HP:0012439) | 1.72202651 |
| 175 | Bile duct proliferation (HP:0001408) | 1.72202651 |
| 176 | Conjunctival telangiectasia (HP:0000524) | 1.72102958 |
| 177 | Eczematoid dermatitis (HP:0000976) | 1.71646381 |
| 178 | Abnormal platelet volume (HP:0011876) | 1.69622845 |
| 179 | Increased mean platelet volume (HP:0011877) | 1.68915142 |
| 180 | Right ventricular cardiomyopathy (HP:0011663) | 1.68757469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.49915001 |
| 2 | ERN1 | 3.88139580 |
| 3 | SIK1 | 3.30215189 |
| 4 | BCKDK | 3.04939131 |
| 5 | LMTK2 | 2.94898737 |
| 6 | TGFBR2 | 2.75182306 |
| 7 | FGFR4 | 2.69674236 |
| 8 | MAP3K14 | 2.64301923 |
| 9 | CAMK1D | 2.45874169 |
| 10 | IRAK3 | 2.42448142 |
| 11 | TAOK3 | 2.23549402 |
| 12 | TYK2 | 2.22846086 |
| 13 | SYK | 2.15537208 |
| 14 | PTK6 | 2.12543722 |
| 15 | EPHB1 | 2.10524017 |
| 16 | TXK | 2.09965476 |
| 17 | TRIB3 | 2.03296735 |
| 18 | TNK2 | 2.02211323 |
| 19 | FLT3 | 1.93184054 |
| 20 | MST4 | 1.91887287 |
| 21 | PKN2 | 1.91472331 |
| 22 | LATS1 | 1.84419887 |
| 23 | FRK | 1.79317914 |
| 24 | INSRR | 1.76792630 |
| 25 | CSK | 1.73785875 |
| 26 | PIK3CG | 1.73136682 |
| 27 | CAMK1G | 1.66064578 |
| 28 | ACVR1B | 1.56017707 |
| 29 | BMPR2 | 1.55165119 |
| 30 | NEK9 | 1.51663449 |
| 31 | IRAK1 | 1.49775658 |
| 32 | PTK2B | 1.49610742 |
| 33 | PTK2 | 1.47037501 |
| 34 | TBK1 | 1.46391057 |
| 35 | GRK1 | 1.45641953 |
| 36 | JAK1 | 1.38535126 |
| 37 | CSF1R | 1.32249761 |
| 38 | MAP3K11 | 1.27246104 |
| 39 | MET | 1.24336577 |
| 40 | MAP2K3 | 1.24096966 |
| 41 | ADRBK2 | 1.20529701 |
| 42 | ITK | 1.18459611 |
| 43 | YES1 | 1.18141451 |
| 44 | SIK3 | 1.17847725 |
| 45 | TAOK1 | 1.17817714 |
| 46 | LCK | 1.12274360 |
| 47 | PRKG2 | 1.11075769 |
| 48 | JAK2 | 1.10762492 |
| 49 | ERBB4 | 1.07785703 |
| 50 | PRKAA2 | 1.06605770 |
| 51 | ABL2 | 1.05738977 |
| 52 | MAPK15 | 1.02645703 |
| 53 | STK10 | 0.98224614 |
| 54 | MYLK | 0.96769941 |
| 55 | KDR | 0.94333231 |
| 56 | DAPK2 | 0.93498446 |
| 57 | MST1R | 0.93208355 |
| 58 | BMX | 0.92077119 |
| 59 | MARK3 | 0.91344559 |
| 60 | PDK1 | 0.90251242 |
| 61 | MATK | 0.89026942 |
| 62 | GRK6 | 0.88483587 |
| 63 | MAP3K2 | 0.88469080 |
| 64 | MAPK11 | 0.88243148 |
| 65 | NLK | 0.88131532 |
| 66 | TRPM7 | 0.86883885 |
| 67 | BTK | 0.85510534 |
| 68 | CDK6 | 0.84327804 |
| 69 | STK24 | 0.83366631 |
| 70 | FGR | 0.82866698 |
| 71 | CDK12 | 0.82851188 |
| 72 | FGFR3 | 0.80648366 |
| 73 | ADRBK1 | 0.80595135 |
| 74 | MAP2K4 | 0.80309145 |
| 75 | GRK5 | 0.80210562 |
| 76 | MAP3K12 | 0.78582348 |
| 77 | ZAP70 | 0.78090510 |
| 78 | BLK | 0.76677190 |
| 79 | MAP3K6 | 0.75608541 |
| 80 | RIPK1 | 0.74560097 |
| 81 | KIT | 0.74418751 |
| 82 | IKBKE | 0.74191968 |
| 83 | CHUK | 0.73252457 |
| 84 | MAP3K5 | 0.72855123 |
| 85 | EPHA3 | 0.72068524 |
| 86 | FGFR2 | 0.71434365 |
| 87 | GRK7 | 0.71138113 |
| 88 | GSK3A | 0.69168407 |
| 89 | MAPK12 | 0.67167015 |
| 90 | JAK3 | 0.66187741 |
| 91 | IRAK2 | 0.65527050 |
| 92 | MAPK4 | 0.65433154 |
| 93 | TEC | 0.65109122 |
| 94 | TTN | 0.64395542 |
| 95 | SGK2 | 0.63747987 |
| 96 | FYN | 0.63057873 |
| 97 | HCK | 0.62163450 |
| 98 | CAMKK2 | 0.62104502 |
| 99 | ERBB2 | 0.61950781 |
| 100 | OXSR1 | 0.61762956 |
| 101 | NTRK1 | 0.61462230 |
| 102 | MAP3K3 | 0.60236658 |
| 103 | IRAK4 | 0.59578078 |
| 104 | PAK4 | 0.57551344 |
| 105 | EGFR | 0.57538434 |
| 106 | MARK2 | 0.56587238 |
| 107 | IKBKB | 0.56578811 |
| 108 | MAP4K1 | 0.56538582 |
| 109 | SGK3 | 0.56384847 |
| 110 | RET | 0.53392635 |
| 111 | WNK3 | 0.53227509 |
| 112 | STK38 | 0.53150194 |
| 113 | PRKACG | 0.51157862 |
| 114 | IGF1R | 0.50823735 |
| 115 | MAP3K7 | 0.50589512 |
| 116 | STK3 | 0.49431383 |
| 117 | FER | 0.48328455 |
| 118 | PRKD2 | 0.47546876 |
| 119 | PDGFRA | 0.46909882 |
| 120 | PDGFRB | 0.45820924 |
| 121 | TLK1 | 0.45271952 |
| 122 | FES | 0.45205371 |
| 123 | NUAK1 | 0.44914012 |
| 124 | LYN | 0.44155847 |
| 125 | TESK2 | 0.42952327 |
| 126 | MAP2K2 | 0.42914925 |
| 127 | MOS | 0.42802609 |
| 128 | MAP3K13 | 0.42082156 |
| 129 | MAPK7 | 0.41991365 |
| 130 | STK11 | 0.41946656 |
| 131 | PINK1 | 0.41586941 |
| 132 | MAP2K1 | 0.40741137 |
| 133 | ABL1 | 0.40212153 |
| 134 | LRRK2 | 0.39981318 |
| 135 | PRKCH | 0.38390497 |
| 136 | PRKAA1 | 0.37876903 |
| 137 | PDPK1 | 0.37793254 |
| 138 | MAPK13 | 0.36411282 |
| 139 | TNIK | 0.36203203 |
| 140 | MAP2K6 | 0.35846020 |
| 141 | HIPK2 | 0.35574001 |
| 142 | MAP3K1 | 0.35276713 |
| 143 | TAOK2 | 0.35119270 |
| 144 | CDC42BPA | 0.34238925 |
| 145 | PRKCQ | 0.33659877 |
| 146 | CAMK1 | 0.33396076 |
| 147 | CDK19 | 0.33242990 |
| 148 | CAMK4 | 0.32092640 |
| 149 | CLK1 | 0.31200313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32218780 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26147549 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18161978 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.09610220 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99348055 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92400896 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86484322 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73529947 |
| 9 | Platelet activation_Homo sapiens_hsa04611 | 2.68237301 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58044169 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56885464 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34690272 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.29880468 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25417324 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18423654 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14949966 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14653347 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14098727 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12252530 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10372537 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03520571 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01172963 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01015494 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.99323885 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94425998 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89804031 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83626240 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83110435 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82781113 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82636727 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79817642 |
| 32 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79424623 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79411502 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78949601 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.78825406 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76166818 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71330843 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71040327 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69121209 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66951911 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.62258075 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61744779 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54599050 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53569456 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53251162 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.48988408 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43081838 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.40697808 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39557038 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35820631 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34515759 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32907794 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.32012221 |
| 54 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.31136496 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27280455 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26219556 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26069355 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25779467 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22983369 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21029578 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19270187 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16829513 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14454157 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13284311 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08758595 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 1.08248381 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07208842 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06422089 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03957612 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02014795 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94053995 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91609839 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89820013 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.88266846 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87289035 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87000986 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86110159 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84741240 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84427274 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.84259469 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.83210374 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82372826 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81675848 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81296835 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79839003 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78899721 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78850282 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77733543 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76031470 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74956845 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74452493 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74329087 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73206482 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73130765 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72861880 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72812584 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72447000 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70433441 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68009393 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65297406 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65236497 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63152342 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.62081959 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62078212 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.61675523 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60189543 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58662640 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58387886 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57825004 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55670967 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55083540 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55069137 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54841118 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54712896 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.53734174 |
| 116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52907933 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51893629 |
| 118 | * Salmonella infection_Homo sapiens_hsa05132 | 0.51392513 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51277056 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50249918 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50179227 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48584004 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48081547 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46591888 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.46172604 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45816303 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45071924 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44680289 |
| 129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44324769 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.43436335 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42684940 |
| 132 | Gap junction_Homo sapiens_hsa04540 | 0.42446015 |
| 133 | Morphine addiction_Homo sapiens_hsa05032 | 0.42414414 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42238016 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42154520 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41736691 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41384637 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40267789 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.37172606 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36128102 |
| 141 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34283505 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28840254 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27670134 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.26246395 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24245557 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.22936651 |
| 147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19110181 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.16848113 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16526481 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15995342 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.15627453 |
| 152 | * Legionellosis_Homo sapiens_hsa05134 | 0.15407892 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14825431 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13553380 |
| 155 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.13373555 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13173264 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12408438 |
| 158 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11132591 |
| 159 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.09347956 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.06428775 |
| 161 | Tuberculosis_Homo sapiens_hsa05152 | 0.05643143 |
| 162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.05553102 |
| 163 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.04154628 |
| 164 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02780158 |
| 165 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | -5.9024334 |
| 166 | Phagosome_Homo sapiens_hsa04145 | -0.0217534 |
| 167 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0203489 |
| 168 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0153651 |
| 169 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0152654 |
| 170 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0150905 |

